Carbenoxolone is a glycyrrhetinic acid analogue and inhibitor of 11β-HSD inhibitor and gap junction connexin channels. It exhibits a wide variety of biological properties, including decreasing infarction size in cerebral ischemia models, decreasing production of IL-23 and Th17 cells, inhibiting marcrophage migration into atria, and preventing development of fatty liver disease. References: Al-Bader MD, Jasem SA, Kilarkaje N. Carbenoxolone exposure during late gestation in rats alters placental expressions of p53 and estrogen receptors. Eur J Pharmacol. 2016 Nov 15;79675-685. doi: 10.1016/j.ejphar.2016.09.035. Epub 2016 Sep 28. PubMed PMID: 27693517.

纯度：≥98%

CAS：5697-56-3